Logo image of CMBT

CMB TECH NV (CMBT) Stock Fundamental Analysis

NYSE:CMBT - New York Stock Exchange, Inc. - BE0003816338 - Common Stock - Currency: USD

9.02  -0.19 (-2.06%)

After market: 9.1997 +0.18 (+1.99%)

Fundamental Rating

4

Overall CMBT gets a fundamental rating of 4 out of 10. We evaluated CMBT against 211 industry peers in the Oil, Gas & Consumable Fuels industry. CMBT has an excellent profitability rating, but there are concerns on its financial health. CMBT has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

CMBT had positive earnings in the past year.
In the past year CMBT had a positive cash flow from operations.
CMBT had positive earnings in 4 of the past 5 years.
Of the past 5 years CMBT 4 years had a positive operating cash flow.
CMBT Yearly Net Income VS EBIT VS OCF VS FCFCMBT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M

1.2 Ratios

CMBT has a better Return On Assets (12.31%) than 88.15% of its industry peers.
CMBT has a Return On Equity of 79.11%. This is amongst the best in the industry. CMBT outperforms 96.21% of its industry peers.
Looking at the Return On Invested Capital, with a value of 5.33%, CMBT is in line with its industry, outperforming 44.55% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for CMBT is significantly below the industry average of 23.70%.
The last Return On Invested Capital (5.33%) for CMBT is well below the 3 year average (9.43%), which needs to be investigated, but indicates that CMBT had better years and this may not be a problem.
Industry RankSector Rank
ROA 12.31%
ROE 79.11%
ROIC 5.33%
ROA(3y)17.5%
ROA(5y)11.27%
ROE(3y)39.6%
ROE(5y)24.4%
ROIC(3y)9.43%
ROIC(5y)N/A
CMBT Yearly ROA, ROE, ROICCMBT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

1.3 Margins

Looking at the Profit Margin, with a value of 72.50%, CMBT belongs to the top of the industry, outperforming 95.73% of the companies in the same industry.
In the last couple of years the Profit Margin of CMBT has grown nicely.
CMBT has a better Operating Margin (35.88%) than 79.62% of its industry peers.
CMBT's Operating Margin has improved in the last couple of years.
Looking at the Gross Margin, with a value of 58.65%, CMBT is in the better half of the industry, outperforming 65.40% of the companies in the same industry.
CMBT's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 35.88%
PM (TTM) 72.5%
GM 58.65%
OM growth 3YN/A
OM growth 5Y14.72%
PM growth 3YN/A
PM growth 5Y49.82%
GM growth 3Y46.27%
GM growth 5Y-0.15%
CMBT Yearly Profit, Operating, Gross MarginsCMBT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50

1

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), CMBT is creating some value.
CMBT has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, CMBT has less shares outstanding
The debt/assets ratio for CMBT is higher compared to a year ago.
CMBT Yearly Shares OutstandingCMBT Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
CMBT Yearly Total Debt VS Total AssetsCMBT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

2.2 Solvency

CMBT has an Altman-Z score of 0.67. This is a bad value and indicates that CMBT is not financially healthy and even has some risk of bankruptcy.
CMBT has a worse Altman-Z score (0.67) than 62.56% of its industry peers.
CMBT has a Debt/Equity ratio of 3.75. This is a high value indicating a heavy dependency on external financing.
With a Debt to Equity ratio value of 3.75, CMBT is not doing good in the industry: 87.20% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 3.75
Debt/FCF N/A
Altman-Z 0.67
ROIC/WACC0.69
WACC7.71%
CMBT Yearly LT Debt VS Equity VS FCFCMBT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B

2.3 Liquidity

A Current Ratio of 0.77 indicates that CMBT may have some problems paying its short term obligations.
The Current ratio of CMBT (0.77) is worse than 71.56% of its industry peers.
A Quick Ratio of 0.70 indicates that CMBT may have some problems paying its short term obligations.
CMBT has a worse Quick ratio (0.70) than 68.72% of its industry peers.
Industry RankSector Rank
Current Ratio 0.77
Quick Ratio 0.7
CMBT Yearly Current Assets VS Current LiabilitesCMBT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

4

3. Growth

3.1 Past

The earnings per share for CMBT have decreased strongly by -79.01% in the last year.
The Earnings Per Share has been growing by 43.41% on average over the past years. This is a very strong growth
Looking at the last year, CMBT shows a very negative growth in Revenue. The Revenue has decreased by -20.34% in the last year.
Measured over the past years, CMBT shows a small growth in Revenue. The Revenue has been growing by 0.55% on average per year.
EPS 1Y (TTM)-79.01%
EPS 3YN/A
EPS 5Y43.41%
EPS Q2Q%-100.41%
Revenue 1Y (TTM)-20.34%
Revenue growth 3Y30.84%
Revenue growth 5Y0.55%
Sales Q2Q%-2.22%

3.2 Future

CMBT is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -29.06% yearly.
The Revenue is expected to grow by 9.37% on average over the next years. This is quite good.
EPS Next Y-69.07%
EPS Next 2Y-32.88%
EPS Next 3Y-29.06%
EPS Next 5YN/A
Revenue Next Year7.15%
Revenue Next 2Y15.37%
Revenue Next 3Y9.37%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
CMBT Yearly Revenue VS EstimatesCMBT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M 800M 1B
CMBT Yearly EPS VS EstimatesCMBT Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 2 4

6

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 7.33 indicates a rather cheap valuation of CMBT.
Based on the Price/Earnings ratio, CMBT is valued cheaply inside the industry as 81.99% of the companies are valued more expensively.
CMBT's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.15.
The Price/Forward Earnings ratio is 5.41, which indicates a rather cheap valuation of CMBT.
90.05% of the companies in the same industry are more expensive than CMBT, based on the Price/Forward Earnings ratio.
When comparing the Price/Forward Earnings ratio of CMBT to the average of the S&P500 Index (21.60), we can say CMBT is valued rather cheaply.
Industry RankSector Rank
PE 7.33
Fwd PE 5.41
CMBT Price Earnings VS Forward Price EarningsCMBT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

CMBT's Enterprise Value to EBITDA is on the same level as the industry average.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 10.63
CMBT Per share dataCMBT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 -4 6

4.3 Compensation for Growth

CMBT has a very decent profitability rating, which may justify a higher PE ratio.
A cheap valuation may be justified as CMBT's earnings are expected to decrease with -29.06% in the coming years.
PEG (NY)N/A
PEG (5Y)0.17
EPS Next 2Y-32.88%
EPS Next 3Y-29.06%

6

5. Dividend

5.1 Amount

CMBT has a Yearly Dividend Yield of 12.49%, which is a nice return.
Compared to an average industry Dividend Yield of 6.66, CMBT pays a better dividend. On top of this CMBT pays more dividend than 92.42% of the companies listed in the same industry.
CMBT's Dividend Yield is rather good when compared to the S&P500 average which is at 2.42.
Industry RankSector Rank
Dividend Yield 12.49%

5.2 History

On average, the dividend of CMBT grows each year by 116.35%, which is quite nice.
CMBT has been paying a dividend for over 5 years, so it has already some track record.
CMBT has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)116.35%
Div Incr Years2
Div Non Decr Years3
CMBT Yearly Dividends per shareCMBT Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 1 2 3 4 5

5.3 Sustainability

CMBT pays out 109.72% of its income as dividend. This is not a sustainable payout ratio.
The Dividend Rate of CMBT has been growing, while earnings will be declining. This means the dividend growth is most likely not sustainable.
DP109.72%
EPS Next 2Y-32.88%
EPS Next 3Y-29.06%
CMBT Yearly Income VS Free CF VS DividendCMBT Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B
CMBT Dividend Payout.CMBT Dividend Payout, showing the Payout Ratio.CMBT Dividend Payout.PayoutRetained Earnings

CMB TECH NV

NYSE:CMBT (6/30/2025, 8:04:00 PM)

After market: 9.1997 +0.18 (+1.99%)

9.02

-0.19 (-2.06%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)05-21 2025-05-21/bmo
Earnings (Next)08-07 2025-08-07/bmo
Inst Owners1.21%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap1.98B
Analysts80
Price Target13.52 (49.89%)
Short Float %6.47%
Short Ratio7.51
Dividend
Industry RankSector Rank
Dividend Yield 12.49%
Yearly Dividend5.68
Dividend Growth(5Y)116.35%
DP109.72%
Div Incr Years2
Div Non Decr Years3
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-99.31%
Min EPS beat(2)-149.02%
Max EPS beat(2)-49.61%
EPS beat(4)1
Avg EPS beat(4)9.95%
Min EPS beat(4)-149.02%
Max EPS beat(4)242.1%
EPS beat(8)5
Avg EPS beat(8)86.48%
EPS beat(12)8
Avg EPS beat(12)69.92%
EPS beat(16)10
Avg EPS beat(16)53.9%
Revenue beat(2)1
Avg Revenue beat(2)0.7%
Min Revenue beat(2)-9.81%
Max Revenue beat(2)11.21%
Revenue beat(4)3
Avg Revenue beat(4)5.75%
Min Revenue beat(4)-9.81%
Max Revenue beat(4)15.33%
Revenue beat(8)6
Avg Revenue beat(8)28.28%
Revenue beat(12)10
Avg Revenue beat(12)38.19%
Revenue beat(16)14
Avg Revenue beat(16)43.66%
PT rev (1m)1.05%
PT rev (3m)0.29%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)-19.86%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.72%
Valuation
Industry RankSector Rank
PE 7.33
Fwd PE 5.41
P/S 1.42
P/FCF N/A
P/OCF 7.39
P/B 1.55
P/tB 1.82
EV/EBITDA 10.63
EPS(TTM)1.23
EY13.64%
EPS(NY)1.67
Fwd EY18.48%
FCF(TTM)-4.28
FCFYN/A
OCF(TTM)1.22
OCFY13.53%
SpS6.35
BVpS5.82
TBVpS4.96
PEG (NY)N/A
PEG (5Y)0.17
Profitability
Industry RankSector Rank
ROA 12.31%
ROE 79.11%
ROCE 6.75%
ROIC 5.33%
ROICexc 5.45%
ROICexgc 5.6%
OM 35.88%
PM (TTM) 72.5%
GM 58.65%
FCFM N/A
ROA(3y)17.5%
ROA(5y)11.27%
ROE(3y)39.6%
ROE(5y)24.4%
ROIC(3y)9.43%
ROIC(5y)N/A
ROICexc(3y)10.41%
ROICexc(5y)N/A
ROICexgc(3y)10.46%
ROICexgc(5y)N/A
ROCE(3y)11.93%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5Y15.98%
ROICexc growth 3YN/A
ROICexc growth 5Y15.87%
OM growth 3YN/A
OM growth 5Y14.72%
PM growth 3YN/A
PM growth 5Y49.82%
GM growth 3Y46.27%
GM growth 5Y-0.15%
F-Score2
Asset Turnover0.17
Health
Industry RankSector Rank
Debt/Equity 3.75
Debt/FCF N/A
Debt/EBITDA 7.03
Cap/Depr 666.34%
Cap/Sales 86.55%
Interest Coverage 3.85
Cash Conversion 39.32%
Profit Quality N/A
Current Ratio 0.77
Quick Ratio 0.7
Altman-Z 0.67
F-Score2
WACC7.71%
ROIC/WACC0.69
Cap/Depr(3y)357.13%
Cap/Depr(5y)252.34%
Cap/Sales(3y)69.97%
Cap/Sales(5y)65.4%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-79.01%
EPS 3YN/A
EPS 5Y43.41%
EPS Q2Q%-100.41%
EPS Next Y-69.07%
EPS Next 2Y-32.88%
EPS Next 3Y-29.06%
EPS Next 5YN/A
Revenue 1Y (TTM)-20.34%
Revenue growth 3Y30.84%
Revenue growth 5Y0.55%
Sales Q2Q%-2.22%
Revenue Next Year7.15%
Revenue Next 2Y15.37%
Revenue Next 3Y9.37%
Revenue Next 5YN/A
EBIT growth 1Y-38.91%
EBIT growth 3YN/A
EBIT growth 5Y15.35%
EBIT Next Year67.95%
EBIT Next 3Y22.95%
EBIT Next 5YN/A
FCF growth 1Y-783.57%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-46.61%
OCF growth 3YN/A
OCF growth 5Y11.04%